We’re excited to announce the beta launch of SAOR™, a new diabetes management system developed by the team at Innovation Zed.
SAOR™ is designed for people using insulin pens. It connects your existing insulin pen and CGM to capture dose data and deliver insights based on your real-time activity. Whether you want more control, less guesswork, or smarter support, SAOR™ is here to help.
Why join the beta?
🔹 Be one of the first people to use this pioneering platform.
🔹 Receive real-time feedback on your insulin use.
🔹 Help shape the future of personalised diabetes care.
🔹 Receive full support from our SAOR team during the trial.
SAOR™ is developed by Innovation Zed, the creators of the InsulCheck product range. Visit our website or click the link below to learn more about the SAOR Diabetes Management System.
Sign up using the link below 👇
https://t.co/uVE4cIaZ9P
Less than two weeks until we touch down in San Francisco! 🇺🇸
We’re excited to connect with leaders and innovators shaping the future of diabetes technology, and to share how #WeCreateFreedom for insulin pen users worldwide.
#DTM2025
We’re thrilled to be exhibiting at the Diabetes Technology Meeting in San Francisco, hosted by the Diabetes Technology Society (DTS). It’s an incredible opportunity to showcase how our solutions are transforming diabetes management, connect with leading experts and innovators from around the world, and explore the latest advancements shaping the future of diabetes technology.
We look forward to meeting many of you there!
#DTM2025
EASD 2025 is almost here!
Next week in Vienna, we’ll be joining the global diabetes community to share insights, exchange ideas, and highlight how our SAOR diabetes management system empowers insulin pen users. If you would like to connect, please don't hesitate to reach out!
#EASD2025
Chicago, here we come! 🇺🇸
We’re excited to join the global diabetes community this week at the @AmDiabetesAssn!
Stop by Booth #1620 to experience how our SAOR Diabetes Management System automates insulin data capture for all insulin pen users.
#ADA2025
And that's a wrap for #ADA2024, enjoy a short recap of a very positive week for us in Orlando! A huge thanks to everyone who came by our booth to learn more about us and what we do, the support was incredible!
We would also like to thank the @AmDiabetesAssn for yet another fantastic event, we’re already looking forward to #ADA2025 in Chicago!
#WeCreateFreedom
Enjoy a short recap of our time at #ATTD2024 in Florence! We would like to thank everyone who came to see us again this year, we are already looking forward to #ATTD2025! Lastly, we would like to thank @attdconf for hosting another wonderful event!
#ATTD2024#T1D#insulinpen #connecteddevices #medicaldevice #connectedcare #digitalhealth
Its finally day #1 of Advanced Technologies & Treatments for Diabetes (ATTD)! If you're in Florence drop by Booth #85 to find out more about InsulCheck DOSE, transforming any insulin pen into a connected digital health solution.
#ATTD2024
#WeCreateFreedom #connectedcare #connectedpen #insulinpen #digitalhealth
We are now two weeks away from @ATTDconf in Florence, Italy!
Come see us at Booth #85 to learn about our latest in add-on technology, InsulCheck DOSE, which can transform any insulin pen into a smart, connected insulin pen!
#ATTD2024#T1D#T2D#connectedhealth#medicaldevices #digitalhealthcare #insulinpen
Excitement is building as we are planning our arrangements to exhibit at this years @ATTDconf event in Florence!
Come speak to us at Booth #85 and learn about how our InsulCheck DOSE™ technology can enhance any diabetes management ecosystem.
#ATTD2024#WeCreateFreedom #connectedcare #connectedpen #insulinpen #digitalhealth
The final day here at @PharmapackEU in Paris! Reach out to us if you’d like to learn more about our DOSE platform technology, transforming any injection pen into a connected digital health solution.
Or please visit our partner @SHL_Medical at booth D60 to find out more about DOSE.
#PharmapackEU
#WeCreateFreedom #connectedhealth #digitalhealth #connectedpen